Armistice Capital »

Lam Research shares owned by Armistice Capital

Quarter-by-quarter ownership of Lam Research (LRCX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Lam Research

Tip: Access up to 7 years of quarterly data

All positions including Lam Research held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lam Research by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.1M 24k 213.66

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Lam Research

BlackRock
Vanguard Group
Vanguard Capital Management
State Street Corporation
Vanguard Portfolio Management
Geode Capital Management
FMR
Invesco
Ameriprise Financial
Morgan Stanley
Northern Trust
Ubs Global Asset Management Americas
Arrowstreet Capital, Limited Partnership
Susquehanna International
Franklin Resources

View all funds holding Lam Research